Literature DB >> 12773138

Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation.

Miyao Matsubara1, Katsuhiko Namioka, Shinji Katayose.   

Abstract

OBJECTIVE: Inflammation has been suggested as a risk factor for the development of atherosclerosis, while some components of metabolic syndrome X have been related to inflammatory markers. We hypothesized that adipocyte secreting protein, adiponectin and leptin, for which have been demonstrated an association with metabolic syndrome X and coronary artery disease, may be associated with inflammatory markers in nondiabetic humans. DESIGN AND METHODS: We measured high-sensitivity C-reactive protein (hs-CRP), as an inflammatory marker, and adiponectin and leptin concentrations in 384 nondiabetic Japanese women (mean+/-s.e.m. age 53.6+/-0.8 Years, body mass index (BMI) 23.0+/-0.2 kg/m(2)) undergoing measurement of markers of metabolic syndrome X.
RESULTS: The women who had a low-grade hs-CRP elevation (>2.0 mg/l) were significantly older and had higher BMI, body fat mass (BFM), total cholesterol (TC), triglyceride (TG), atherogenic index (AI=(TC-HDLC)/HDLC), where HDLC is high-density lipoproten-cholesterol), fasting blood glucose and leptin concentrations before and after adjustment for BMI or BFM, while lower HDLC and adiponectin concentrations before and after adjustment compared with women with normal CRP levels (<0.5 mg/l). BMI, BFM, TG, AI and leptin before and after adjustment were found to be correlated with hs-CRP levels, while HDLC and adiponectin before and after adjustment were inversely correlated (all P<0.0001). hs-CRP was independently associated with white blood cell count, blood urea nitrogen and AI and inversely with adiponectin/BFM in the stepwise regression analysis model.
CONCLUSIONS: These data demonstrate a significant decrease in plasma adiponectin in low-grade chronic inflammation, and suggest that there is an important linkage between inflammation/adipose tIssue/atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773138     DOI: 10.1530/eje.0.1480657

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  17 in total

1.  Circulating adiponectin concentrations in patients with congestive heart failure.

Authors:  J George; S Patal; D Wexler; Y Sharabi; E Peleg; Y Kamari; E Grossman; D Sheps; G Keren; A Roth
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

2.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

Authors:  Yukihiro Takemura; Noriyuki Ouchi; Rei Shibata; Tamar Aprahamian; Michael T Kirber; Ross S Summer; Shinji Kihara; Kenneth Walsh
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

3.  CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.

Authors:  Sridevi Devaraj; Michael M Swarbrick; Uma Singh; Beverley Adams-Huet; Peter J Havel; Ishwarlal Jialal
Journal:  Am J Clin Pathol       Date:  2008-05       Impact factor: 2.493

Review 4.  Metabolic syndrome X: an inflammatory condition?

Authors:  Undurti N Das
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

5.  Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality.

Authors:  Hwee Teoh; Adrian Quan; K W Annie Bang; Guilin Wang; Fina Lovren; Vivian Vu; Jack J Haitsma; Paul E Szmitko; Mohammed Al-Omran; Chao-Hung Wang; Milan Gupta; Mark D Peterson; Haibo Zhang; Lawrence Chan; John Freedman; Gary Sweeney; Subodh Verma
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-15       Impact factor: 4.310

6.  Leptin-to-Adiponectin Ratio is Related to Low Grade Inflammation and Insulin Resistance Independent of Obesity in Non-Diabetic Taiwanese: A Cross-Sectional Cohort Study.

Authors:  Hsin-Hua Chou; Lung-An Hsu; Semon Wu; Ming-Sheng Teng; Yu-Chen Sun; Yu-Lin Ko
Journal:  Acta Cardiol Sin       Date:  2014-05       Impact factor: 2.672

7.  The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin.

Authors:  Tamar Aprahamian; Ramon G Bonegio; Christophe Richez; Kei Yasuda; Lo-Ku Chiang; Kaori Sato; Kenneth Walsh; Ian R Rifkin
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 8.  Adipocytokines and liver disease.

Authors:  Yoshihiro Kamada; Tetsuo Takehara; Norio Hayashi
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

Review 9.  Adiponectin as an anti-inflammatory factor.

Authors:  Noriyuki Ouchi; Kenneth Walsh
Journal:  Clin Chim Acta       Date:  2007-02-02       Impact factor: 3.786

10.  Adiponectin is a link among inflammation, insulin resistance, and high-density lipoprotein cholesterol but is not associated with paraoxonase activity in premenopausal women.

Authors:  Pinar Cetinalp-Demircan; Selda Bekpinar; Figen Gurdol; Yusuf Orhan
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.